Abstract
Peri-procedural anticoagulant management hinges on the balance of hemorrhagic and thrombotic complications. The radiologist is tasked with accurately assessing the hemorrhagic risk for patients undergoing procedures, taking into account procedural bleeding rates, underlying coagulopathy based on lab tests, and use of anticoagulants. The purpose of this article is to provide a contemporary review of commonly used anticoagulants and, incorporating published evidence, review their management related to image-guided procedures.
Similar content being viewed by others
References
Coleman JL, Alberts MJ (2006) Effect of aspirin dose, preparation, and withdrawal on platelet response in normal volunteers. Am J Cardiol 98(6):838–841
Patrono C, Baigent C, Hirsh J, Roth G (2008) Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 133(6):199S–233S
Benzon HT, Avram MJ, Green D, Bonow RO (2013) New oral anticoagulants and regional anaesthesia. Br J Anaesth 111(1):i96–i113
Narouze S, Benzon HT, Provenzano DA, et al. (2015) Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med 40(3):182–212
Jimenez AH, Stubbs ME, Tofler GH, et al. (1992) Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men. Am J Cardiol 69(3):258–262
Douketis JD, Berger PB, Dunn AS, et al. (2008) The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 133(6):299S–339S
Moshfegh K, Redondo M, Julmy F, et al. (2000) Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy. J Am Coll Cardiol 36(3):699–705
Douketis JD, Spyropoulos AC, Spencer FA, et al. (2012) Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2):e326S–e350S
Baron TH, Kamath PS, McBane RD (2013) Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med 368(22):2113–2124
Walenga JM, Lyman GH (2013) Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: a review of pharmacologic and clinical differences and applications in patients with cancer. Crit Rev Oncol/Hematol 88(1):1–18
Asai F, Jakubowski JA, Naganuma H, et al. (2006) Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humans. Platelets 17(4):209–217
Gurbel PA, Bliden KP, Butler K, et al. (2009) Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor vs. clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 120(25):2577–2585
Abdulsattar Y, Ternas T, Garcia D (2011) Vorapaxar: targeting a novel antiplatelet pathway. Pharm Ther 36(9):564–568
Runyon BA (2009) Management of adult patients with ascites due to cirrhosis: an update. Hepatology 49(6):2087–2107
Atwell TD, Smith RL, Hesley GK, et al. (2010) Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. Am J Roentgenol 194(3):784–789
Westheim BH, Østensen AB, Aagenæs I, Sanengen T, Almaas R (2012) Evaluation of risk factors for bleeding after liver biopsy in children. J Pediatr Gastroenterol Nutr 55(1):82–87
Corapi KM, Chen JL, Balk EM, Gordon CE (2012) Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis 60(1):62–73
Mackinnon B, Fraser E, Simpson K, Fox JG, Geddes C (2008) Is it necessary to stop antiplatelet agents before a native renal biopsy? Nephrol Dial Transplant 23(11):3566–3570
Leavitt DA, Theckumparampil N, Moreira DM, et al. (2014) Second prize: continuing aspirin therapy during percutaneous nephrolithotomy: unsafe or under-utilized? J Endourol 28(12):1399–1403
Song YS, Park CM, Park KW, et al. (2013) Does antiplatelet therapy increase the risk of hemoptysis during percutaneous transthoracic needle biopsy of a pulmonary lesion? Am J Roentgenol 200(5):1014–1019
Tai R, Dunne RM, Trotman-Dickenson B, et al. (2016) Frequency and severity of pulmonary hemorrhage in patients undergoing percutaneous CT-guided transthoracic lung biopsy: single-institution experience of 1175 cases. Radiology 279(1):287–296
Chetlen AL, Kasales C, Mack J, Schetter S, Zhu J (2013) Hematoma formation during breast core needle biopsy in women taking antithrombotic therapy. Am J Roentgenol 201(1):215–222
Somerville P, Seifert PJ, Destounis SV, Murphy PF, Young W (2008) Anticoagulation and bleeding risk after core needle biopsy. Am J Roentgenol 191(4):1194–1197
Abu-Yousef MM, Larson JH, Kuehn DM, Wu AS, Laroia AT (2011) Safety of ultrasound-guided fine needle aspiration biopsy of neck lesions in patients taking antithrombotic/anticoagulant medications. Ultrasound Quart 27(3):157–159
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women (1994). CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 343(8898):619–629
Whellan DJ, Tricoci P, Chen E, et al. (2014) Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). J Am Coll Cardiol 63(11):1048–1057
Collet JP, Himbet F, Steg PG (2000) Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 76(2–3):257–258
Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27(22):2667–2674
Sibon I, Orgogozo JM (2004) Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology 62(7):1187–1189
Baron TH, Kamath PS, McBane RD (2014) New anticoagulant and antiplatelet agents: a primer for the gastroenterologist. Clin Gastroenterol Hepatol 12(2):187–195
Holbrook A, Schulman S, Witt DM (2012) Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2):e152S–e184S
Hibbert RM, Atwell TD, Lekah A, et al. (2013) Safety of ultrasound-guided thoracentesis in patients with abnormal preprocedural coagulation parameters. Chest 144(2):456–463
Patel MD, Joshi SD (2011) Abnormal preprocedural international normalized ratio and platelet counts are not associated with increased bleeding complications after ultrasound-guided thoracentesis. Am J Roentgenol 197(1):W164–W168
Lin CH, Shih FY, Ma MM, et al. (2005) Should bleeding tendency deter abdominal paracentesis? Dig Liver Dis 37(12):946–951
Ahmed I, Gertner E (2012) Safety of arthrocentesis and joint injection in patients receiving anticoagulation at therapeutic levels. Am J Med 125(3):265–269
Wahl MJ (1998) Dental surgery in anticoagulated patients. Arch Intern Med 158(15):1610–1616
Loke C, Ali SS, Johari V (2012) Pharmacology of anticoagulants. Disease-a-Month 58(8):424–430
Blann AD, Landray MJ, Lip GY (2002) ABC of antithrombotic therapy: an overview of antithrombotic therapy. BMJ 325(7367):762–765
Hirsh J, Raschke R, Warkentin TE, et al. (1995) Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 108(4):258S–275S
Franchini M, Bonfanti C, Mannucci PM (2015) Management of bleeding associated with new oral anticoagulants. Semin Thromb Hemost 41(7):788–801
Ogata K, Mendell-Harary J, Tachibana M, et al. (2010) Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers. J Clin Pharmacol 50(7):743–753
Deykin D, Gurewich V, Harker L, Hirsch J (1977) Treating thromboembolic disease. Geriatrics 32(10):119–121
Velibey Y, Golcuk Y, Ekmekci A, et al. (2015) Tirofiban-induced acute profound thrombocytopenia: what is the optimal approach to treatment? Platelets 26(2):197–198
Lipsky AH, Farooqui MZ, Tian X, et al. (2015) Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib. Haematologica 100(12):1571–1578
Imbruvica (R) [package insert]. Pharmacyclics LLC, Sunnyvale, CA; June 2016. Available from: https://www.imbruvicahcp.com/docs/librariesprovider2/pdf-downloads/prescribing_information.pdf. Accessed 14 June 2016
Lee JM, Hays JL, Noonan AM, et al. (2013) Feasibility and safety of sequential research-related tumor core biopsies in clinical trials. Cancer 119(7):1357–1364
Erinjeri JP, Fong AJ, Kemeny NE, et al. (2011) Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement. Cancer 117(6):1296–1301
Abrams DA, Hanson JA, Brown JM, et al. (2015) Timing of surgery and bevacizumab therapy in neurosurgical patients with recurrent high grade glioma. J Clin Neurosci 22(1):35–39
Thornton AD, Ravn P, Winslet M, Chester K (2006) Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer. Br J Surg 93(12):1456–1463
Powles T, Kayani I, Blank C, et al. (2011) The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer. Annal Oncol 22(5):1041–1047
Meijer WE, Heerdink ER, Nolen WA, et al. (2004) Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 164(21):2367–2370
Skop BP, Brown TM (1996) Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 37(1):12–16
de Abajo FJ, Rodriguez LA, Montero D (1999) Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 319(7217):1106–1109
Jeong BO, Kim SW, Kim SY, et al. (2014) Use of serotonergic antidepressants and bleeding risk in patients undergoing surgery. Psychosomatics 55(3):213–220
Srivastava KC (1986) Evidence for the mechanism by which garlic inhibits platelet aggregation. Prostaglandins, Leukot Med 22(3):313–321
Stanger MJ, Thompson LA, Young AJ, Lieberman HR (2012) Anticoagulant activity of select dietary supplements. Nutr Rev 70(2):107–117
Koch E (2005) Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. Phytomedicine 12(1–2):10–16
Harker LA, Kelly AB, Hanson SR, et al. (1993) Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Circulation 87(3):1017–1029
Gajic O, Rana R, Winters JL, et al. (2007) Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 176(9):886–891
Webert KE, Blajchman MA (2003) Transfusion-related acute lung injury. Transfus Med Rev 17(4):252–262
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was received for this study.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Statement of informed consent was not applicable since the manuscript does not contain any patient data.
Rights and permissions
About this article
Cite this article
Atwell, T.D., Wennberg, P.W., McMenomy, B.P. et al. Peri-procedural use of anticoagulants in radiology: an evidence-based review. Abdom Radiol 42, 1556–1565 (2017). https://doi.org/10.1007/s00261-016-1027-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-016-1027-x